3.—(1) Section 24(2) of the Act and regulation 5 of the Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021 (G.N. No. S 1036/2021) do not apply to a person (A) who holds a licence to provide a clinical laboratory service in respect of A’s appointment of an individual as a Clinical Governance Officer where the individual —| (a) | was, immediately before 3 January 2022, employed by A to manage any premises in which a clinical laboratory service is provided by A and continues to be so employed after that date; and | | (b) | had, immediately before that date, held a valid licence under the repealed Act in relation to the use of the premises as a clinical laboratory. [S 850/2023 wef 18/12/2023] |
| (2) Paragraph (1) only applies so long as every laboratory discipline and specified test provided or that is to be provided as part of the clinical laboratory service was, immediately before 3 January 2022, also provided in the premises. |
(3) Section 24(2) of the Act and regulation 6 of the Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021 do not apply to a person (B) who holds a licence to provide a radiological service in respect of B’s appointment of an individual as a Clinical Governance Officer where the individual —| (a) | was, immediately before 3 January 2022, employed by B to manage any premises in which a radiological service is provided by B and continues to be so employed after that date; and | | (b) | had, immediately before that date, held a valid licence under the repealed Act in relation to the use of the premises as a clinical laboratory. [S 850/2023 wef 18/12/2023] |
|
| (4) Paragraph (3) only applies so long as every imaging modality provided or that is to be provided as part of the radiological service was, immediately before 3 January 2022, also provided in the premises. |
(5) Section 24(2) of the Act and regulation 4 of the Healthcare Services (Cord Blood Banking Service) Regulations 2021 (G.N. No. S 1037/2021) do not apply to a person (C) who holds a licence to provide a cord blood banking service in respect of C’s appointment of an individual as a Clinical Governance Officer where the individual —| (a) | was, immediately before 3 January 2022, employed by C to manage any premises in which a cord blood banking service is provided by C and continues to be so employed after that date; and | | (b) | had, immediately before that date, held a valid licence under the repealed Act in relation to the use of the premises as a clinical laboratory. [S 850/2023 wef 18/12/2023] [S 850/2023 wef 18/12/2023] |
|
(5A) Section 24(2) of the Act and regulation 7(1)(b) of the Healthcare Services (Nursing Home Service) Regulations 2023 (G.N. No. S 849/2023) do not apply to a person (D) who holds a licence to provide a nursing home service in respect of D’s appointment of an individual as a Clinical Governance Officer, if all of the following are satisfied:| (a) | D had, immediately before 18 December 2023, held a valid licence under the repealed Act in relation to the use of any premises as a nursing home; | | (b) | the premises mentioned in sub‑paragraph (a) are, from and including that date, D’s approved permanent premises for the provision of the nursing home service; | | (c) | the individual is a registered nurse who —| (i) | is not subject to any condition imposed on his or her registration by the Singapore Nursing Board under section 17(2) of the Nurses and Midwives Act 1999; and | | (ii) | immediately before 18 December 2023, had performed all the functions of a Clinical Governance Officer in respect of the nursing home at the premises mentioned in sub‑paragraph (a). [S 850/2023 wef 18/12/2023] |
|
|
(6) In this paragraph —“imaging modality” means —| (a) | any imaging modality set out in paragraph 1(a) of Part 2 of the Schedule to the Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021; | | (b) | the provision of minimally invasive image-guided biopsy of breast, thyroid, superficial lump or bump or any superficial lymph node; | | (c) | bone densitometry; or | | (d) | ultrasound; |
|
| “laboratory discipline” means any laboratory discipline set out in paragraph 1(a) of Part 1 of the Schedule to the Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021; |
| “specified test” means any test set out in paragraph 1(b) of Part 1 of the Schedule to the Healthcare Services (Clinical Laboratory Service and Radiological Service) Regulations 2021. [S 422/2023 wef 26/06/2023] |
|
|